home · filing · 0001641172-25-013942
8-K filed June 6, 2025, 7:59 PM ET
ticker BMRA
CIK 0000073290
leadership
confidence high
sentiment neutral
materiality 0.50
Biomerica appoints Eric Chin to board; Cathy Coste resigns effective June 4
BIOMERICA INC
Cathy Coste resigned as director effective June 4, 2025; no disagreement with the company.
Eric Chin appointed as independent director and Audit Committee Chair, effective same date.
Chin is CFO of Akido Labs, helped raise $60M; will receive $41K annual cash and 10,000 restricted shares.
Chin also joins Nominating/Governance and Compensation Committees.
No family relationships or transactions requiring disclosure; board determined independent per Nasdaq rules.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2025-06-04
Filed June 6, 2025, 7:59 PM ET
On the same date, the Board appointed Mr. Eric Chin to serve as an independent member of the Board, effective immediately
Departed
Cathy Coste
Director
Effective 2025-06-04
Successor Eric Chin
Filed June 6, 2025, 7:59 PM ET
Effective June 4, 2025, Ms. Cathy Coste stepped down as a member of the Board of Directors
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eric Chin was appointed as Director and Audit Committee Chair at BIOMERICA INC.
Action appointed
Role Director and Audit Committee Chair
Exact text from the filing
On the same date, the Board appointed Mr. Eric Chin to serve as an independent member of the Board, effective immediately
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Cathy Coste resigned as Director at BIOMERICA INC.
Action resigned
Role Director
Exact text from the filing
Effective June 4, 2025, Ms. Cathy Coste stepped down as a member of the Board of Directors
View on SEC.gov
Source: SEC EDGAR
accession 0001641172-25-013942
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.